Sabet Donya T, Yu Hainian, Prior Luke, Wedisinghe Lilantha
Obstetrics and Gynecology, Ipswich Hospital, Brisbane, AUS.
Faculty of Medicine, Griffith University, Gold Coast, AUS.
Cureus. 2025 Mar 17;17(3):e80702. doi: 10.7759/cureus.80702. eCollection 2025 Mar.
Trichomoniasis is an STI caused by a microscopic parasite known as . It is considered one of the most widespread nonviral STDs globally. Trichomoniasis during pregnancy can lead to complications such as early rupture of membranes and premature birth. The standard treatment for trichomoniasis in adults, including pregnant individuals, is metronidazole. Recurrent cases may occur due to factors such as incomplete treatment, reinfection, or metronidazole resistance. In cases of persistent trichomoniasis where noncompliance and reinfection have been ruled out, metronidazole resistance should be considered. We present the case of a 39-year-old woman, gravida 4, para 3, with persistent trichomoniasis unresponsive to multiple courses of metronidazole, suggesting potential metronidazole resistance. She experienced recurrent symptoms of threatened preterm labor, likely due to uterine irritability caused by trichomoniasis. While various treatment regimens are available for metronidazole resistance, their safety profiles have not been evaluated during pregnancy. Further research is essential to identify a safe and effective treatment for metronidazole-resistant trichomoniasis in pregnancy.
滴虫病是一种由名为毛滴虫的微小寄生虫引起的性传播感染。它被认为是全球最普遍的非病毒性性传播疾病之一。孕期滴虫病可导致胎膜早破和早产等并发症。包括孕妇在内的成人滴虫病的标准治疗药物是甲硝唑。由于治疗不彻底、再次感染或甲硝唑耐药等因素,可能会出现复发病例。在排除不依从和再次感染的持续性滴虫病病例中,应考虑甲硝唑耐药。我们报告一例39岁女性病例,孕4产3,患有持续性滴虫病,对多疗程甲硝唑治疗无反应,提示可能存在甲硝唑耐药。她反复出现先兆早产症状,可能是由滴虫病引起的子宫激惹所致。虽然有多种治疗方案可用于甲硝唑耐药情况,但它们在孕期的安全性尚未得到评估。进一步的研究对于确定孕期甲硝唑耐药性滴虫病的安全有效治疗方法至关重要。